SCHEMBL350916

SCHEMBL350916

C=CCOCC(=C)C(=O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
LMNA P02545 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HCAR2 Q8TDS4 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
MAPK1 P28482 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A3 Q01959 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP3A4 P08684 1/20 0.41
TGM2 P21980 1/20 0.40
ALOX15 P16050 1/20 0.40
GRM5 P41594 1/20 0.39
FAAH O00519 1/20 0.39
HTT P42858 1/20 0.38
CA12 O43570 1/20 0.38
AKR1B10 O60218 1/20 0.38
AKR1B1 P15121 1/20 0.38
CA4 P22748 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25802966 0.92 ALDH1A1 (0.41) ALDH1A1LMNASMN1; SMN2HCAR2L3MBTL1
SCHEMBL1520510 0.88 ALDH1A1 (0.52) ALDH1A1LMNASMN1; SMN2HCAR2L3MBTL1
SCHEMBL20261891 0.82 ALDH1A1 (0.46) ALDH1A1LMNASMN1; SMN2HCAR2L3MBTL1
SCHEMBL3346559 0.81 ALDH1A1 (0.49) ALDH1A1LMNASMN1; SMN2HCAR2L3MBTL1
SCHEMBL27545595 0.81 SMN1; SMN2 (0.48) ALDH1A1LMNASMN1; SMN2HCAR2L3MBTL1
SCHEMBL8397728 0.81 CYP3A4 (0.53) ALDH1A1LMNASMN1; SMN2HCAR2L3MBTL1
SCHEMBL8370457 0.81 LMNA (0.48) ALDH1A1LMNASMN1; SMN2HCAR2L3MBTL1
SCHEMBL23704705 0.80 SMN1; SMN2 (0.50) ALDH1A1LMNASMN1; SMN2HCAR2L3MBTL1
SCHEMBL352013 0.80 CYP3A4 (0.40) ALDH1A1SMN1; SMN2KMT2ACYP3A4CA12
SCHEMBL352190 0.79 THRB (0.55) ALDH1A1SMN1; SMN2L3MBTL1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024128086-A1 CURABLE COMPOSITION, LAMINATE, AND METHOD FOR PRODUCING LAMINATE 富士フイルム株式会社 2024-06-20 WO disclosed
US-11987658-B2 Curable resin composition and method of manufacturing article CANON KABUSHIKI KAISHA (JP) 2024-05-21 US disclosed
WO-2023248976-A1 POLYMER AND METHOD FOR PRODUCING SAME, PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, AND MONOMER COMPOUND AND METHOD FOR PRODUCING SAME 株式会社日本触媒 2023-12-28 WO disclosed
WO-2023195398-A1 ADHESIVE COMPOSITION, ADHESIVE FILM FOR CIRCUIT CONNECTION, CIRCUIT CONNECTION STRUCTURE, AND METHOD OF PRODUCING SAME 株式会社レゾナック 2023-10-12 WO disclosed
US-20230240947-A1 DENTAL ADHESIVE COMPOSITION AND DENTAL MATERIAL MITSUI CHEMICAIS, INC. (JP) 2023-08-03 US disclosed
WO-2023127300-A1 NON-AQUEOUS SECONDARY BATTERY BINDER POLYMER, NON-AQUEOUS SECONDARY BATTERY BINDER COMPOSITION, AND NON-AQUEOUS SECONDARY BATTERY ELECTRODE 株式会社レゾナック 2023-07-06 WO disclosed
EP-4162920-A1 DENTAL ADHESIVE COMPOSITION AND DENTAL MATERIAL Mitsui Chemicals, Inc. (JP) 2023-04-12 EP disclosed
US-20220282013-A1 CURABLE RESIN COMPOSITION AND METHOD OF MANUFACTURING ARTICLE CANON KABUSHIKI KAISHA (JP) 2022-09-08 US disclosed
WO-2020162475-A1 CURABLE RESIN COMPOSITION キヤノン株式会社 2020-08-13 WO disclosed
US-10449124-B2 Polymerizable composition for dental use GC CORPORATION (JP) 2019-10-22 US disclosed
EP-3335688-A1 POLYMERIZABLE DENTAL COMPOSITION GC Corporation (JP) 2018-06-20 EP disclosed
US-20180037758-A1 Ink Composition For Three-Dimensional Modeling, Ink Set, And Method For Producing Three-Dimensional Model Konica Minolta, Inc. (JP) 2018-02-08 US disclosed
EP-2415751-B1 ALPHA-(UNSATURATED ALKOXYALKYL) ACRYLATE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF NIPPON CATALYTIC CHEM IND (JP) 2014-11-26 EP disclosed
US-8796492-B2 α-(unsaturated alkoxyalkyl) acrylate composition and process for production thereof NIPPON SHOKUBAI CO., LTD. (JP) 2014-08-05 US disclosed
EP-2383317-B1 ALPHA-ALLYLOXYMETHYLACRYLIC ACID-BASED COPOLYMER, RESIN COMPOSITION, AND USE THEREOF NIPPON CATALYTIC CHEM IND (JP) 2013-10-23 EP disclosed
US-8497332-B2 α-Allyloxymethylacrylic acid-based copolymer, resin compositions, and use thereof NIPPON SHOKUBAI CO., LTD. (JP) 2013-07-30 US disclosed
EP-2415751-A1 ALPHA-(UNSATURATED ALKOXYALKYL) ACRYLATE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF Nippon Shokubai Co., Ltd. (JP) 2012-02-08 EP disclosed
US-20120016095-A1 a-(UNSATURATED ALKOXYALKYL) ACRYLATE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF NIPPON SHOKUBAI CO., LTD. (JP) 2012-01-19 US disclosed
EP-2383317-A1 ALPHA-ALLYLOXYMETHYLACRYLIC ACID-BASED COPOLYMER, RESIN COMPOSITION, AND USE THEREOF Nippon Shokubai Co., Ltd. (JP) 2011-11-02 EP disclosed
US-20110263805-A1 ALPHA-ALLYLOXYMETHYLACRYLIC ACID-BASED COPOLYMER, RESIN COMPOSITIONS, AND USE THEREOF NIPPON SHOKUBAI CO., LTD. (JP) 2011-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10449124-B2 Polymerizable composition for dental use CAD, MDN1, PAM ALDH1A1 1401/4885LMNA 3951/4885SMN1; SMN2 4129/4885
US-20230240947-A1 DENTAL ADHESIVE COMPOSITION AND DENTAL MATERIAL CAD, CDH1, ITGA1 ALDH1A1 435/4885LMNA 2937/4885SMN1; SMN2 4121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.